Épisodes

  • Revolutionizing Clinical Trial Protocols - Life Sciences Today Podcast Episode 58
    Apr 24 2026

    We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Pedro Coelho, Founder and CEO at Biorce! In this episode, I sit down with Coelho to explore how his team went from flagging protocol mistakes to building AI that fixes them — and in doing so, became the first company to submit an AI-generated protocol to the FDA. Coehlo breaks down how Biorce can generate a best-in-class clinical trial protocol in under 5 minutes, why risk-based remote monitoring is the industry’s biggest anti-pattern, and what a “one-click clinical trial” could look like by the end of 2026.

    Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

    • Tell me about your journey – how does a European Founder like you, and a team like yours, get into a space that traditionally has been filled with American companies?
    • What is your value creation?
    • What is your business model? How do you make money from getting it right faster?
    • What are three things you want to do for your customers in 2026?
    • What is the biggest anti-pattern in clin-ops today?

    Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

    Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

    • Apple Podcasts
    • Spotify
    • iHeartRadio
    • Amazon Music
    • Pandora
    • YouTube

    Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

    If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

    Thanks so much for listening!

    Afficher plus Afficher moins
    23 min
  • NeuraLight is Reinventing Neurology's Gold Standard - Life Sciences Today Podcast Episode 57
    Apr 17 2026
    We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Eddie Ben-Ami, Founder and CEO at NeuraLight! NeuraLight is tackling one of neurology’s biggest problems: how crudely we measure disease progression in conditions like Parkinson’s, MS, ALS, and Huntington’s. Despite MRI and gene sequencing, the current “gold standard” is pushing patients to test balance, or asking caregivers how hard it is to adjust clothes in bed. Ben-Ami explains how NeuraLight replaces this with a 10‑minute, tablet-based eye-movement test using a standard camera. By leveraging decades of visual-system research (largely from primate studies), they extract functional biomarkers tied to specific neural pathways and brain regions. The result: objective, quantitative measures of brain function that are highly sensitive to change over time. Over the past four years, NeuraLight has run large longitudinal studies on thousands of patients across multiple neurodegenerative diseases. In Parkinson’s, they’ve shown their metrics are 10x more sensitive to change than the existing clinical gold standard, with results being presented at ADPD in Copenhagen alongside the inventors of that standard. Commercially, NeuraLight is already being paid as a per-test diagnostic in five pharma drug trials (Phase 1 and 2), where their measures serve as secondary/exploratory endpoints. Their moat is a growing, hard-to-replicate dataset linking eye movements to rich clinical data. Looking ahead to 2026, they’re focused on successful readouts from ongoing trials, expanding into psychiatry, and bringing their technology into preventative-care platforms so even healthy people can track brain function—before catastrophe strikes. Check out the main topics of discussion for this episode of the Life Sciences Today podcast: Tell me about your journey.What does NeuraLight do?You do a lot of work with neurodegenerative diseases – Parkinson’s, MS, ALS, and Huntington’s, specifically – where are you holding right now in terms of product development?What is your value creation?In these drug trials, are you the primary endpoint or a secondary endpoint where they’re collecting an additional CRF together with their primary endpoint?The primary endpoint is the gold standard, and no one will talk to you until you can show that you’re at least as good as the gold standard. So, at the end of the trial, have you thought about taking the data and doing a retrospective analysis to see how well your exploratory endpoint correlates with the primary endpoint? Can you piggyback on these trials to use the data to validate your measures?What is your business model? How do you capture value from this?What’s your moat? What prevents someone from doing the same thing you’re doing?What are three things you want to do for your customers in 2026?Do you need a 510(k) from the FDA to clear these diagnostics?What is the biggest anti-pattern in your industry? Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business. Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform: Apple PodcastsSpotifyiHeartRadioAmazon MusicPandoraYouTube Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn. If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes. Thanks so much for listening!
    Afficher plus Afficher moins
    41 min
  • AI Agents Won't Replace CROs — They'll Save Them - Life Sciences Today Podcast Episode 56
    Apr 10 2026

    We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Alison Holland, Chief Customer Officer at Medable! In this episode, I talk with Holland about how her journey from London nurse to Covance veteran to digital trial leader shapes Medable’s strategy.

    Holland started at the bedside and then spent nearly 20 years at a major CRO – Covance. She learned where trials really break: overloaded sites, fragmented systems, and patients battling logistics instead of disease. Medable’s answer is a reusable SaaS platform plus tightly scoped AI agents—first for CRAs, then for TMF, and next for sites—that automate the manual, low‑value work while keeping humans firmly in the loop.

    She walks through concrete wins: PRO compliance jumping from ~75% to 95%, 20% more primary endpoint data, and up to 100 hours saved in study startup by configuring from therapeutic‑area libraries instead of rebuilding from scratch.

    Holland’s chosen industry anti‑pattern is “change fatigue”: an exhausted ecosystem that no longer believes transformation will stick. Her counter is precision use cases that deliver undeniable value, build momentum, and make it possible to say, credibly, “Yes, we can” this time.

    Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

    • Tell me about your journey.
    • Who are your customers and how do you create value for them?
    • What’s Medable’s sweet spot for the size of the customer, the kind of customer, or the phase of the study?
    • We saw this recurring pattern where the decisions would be taken in the last month before the trial, and a subpattern where, in the first two weeks, there would very often be a protocol revision. Is that your experience as well?
    • Do you have to do a custom build for every customer and every trial?
    • How do you capture the value?
    • Are we going to see AI Agents replacing CROs in our lifetime?
    • What are three things you want to do for your customers in 2026?
    • What is the biggest anti-pattern in the clinical R&D industry today?

    Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

    Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

    • Apple Podcasts
    • Spotify
    • iHeartRadio
    • Amazon Music
    • Pandora
    • YouTube

    Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

    If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

    Thanks so much for listening!

    Afficher plus Afficher moins
    39 min
  • Leadership, Moats, and the Next Phase of Clinical Research - Life Sciences Today Podcast Episode 55
    Apr 3 2026

    We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Kim Boericke, the new CEO at Veristat! In this episode, I sit down with Kim to explore what it really takes to build and lead a durable CRO in a rapidly shifting life sciences landscape. We discuss Kim’s leadership journey, how value is created and captured in services-heavy businesses, and what Veristat is prioritizing for customers over the next 12 months. The conversation then goes deeper into the idea of moats—what makes a CRO genuinely hard to copy, what compounds over time, and how strategic decisions today shape defensibility five years out.

    Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

    • Tell me about your journey.
    • How do you create value for your customers?
    • How do you capture the value?
    • What are three things you’d like to achieve in the next 12-18 months?
    • What makes a CRO genuinely hard to copy?
    • What compounds over time? How do the strategic decisions you make today shape out defensibility five years from now?

    Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

    Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

    • Apple Podcasts
    • Spotify
    • iHeartRadio
    • Amazon Music
    • Pandora
    • YouTube

    Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

    If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

    Thanks so much for listening!

    Afficher plus Afficher moins
    32 min
  • Virtual Labs with Josh Haimson - Life Sciences Today Podcast Episode 54
    Mar 27 2026

    We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Josh Haimson, Co-Founder and CEO at Inductive Bio! Josh Haimson joins me to talk about how their virtual lab can run millions of in silico experiments to predict how molecules will behave in the body and surface the strongest hypotheses to test in the wet lab.

    Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

    • Tell me about your journey.
    • How do you create value for your customers?
    • How do you measure the value?
    • What are three things you’d like to achieve in the next 12-18 months?

    Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

    Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

    • Apple Podcasts
    • Spotify
    • iHeartRadio
    • Amazon Music
    • Pandora
    • YouTube

    Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

    If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

    Thanks so much for listening!

    Afficher plus Afficher moins
    27 min
  • Beyond the EMR: Simon Arkell Rewires Clinical Trials - Life Sciences Today Podcast Episode 53
    Mar 20 2026

    We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Olympian-turned-founder Simon Arkell joins Life Sciences Today to explain how Ryght.ai is reinventing clinical trial site selection. He unpacks digital twins for 100,000+ sites, AI agents, and why EMR-centric models are an anti-pattern—showing how sponsors can slash enrollment risk, save hundreds of millions, and scale globally.

    Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

    • Tell me about your journey.
    • How do you create value for your customers?
    • How do you measure the value?
    • What are three things you’d like to achieve in the next 12-18 months?

    Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

    Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

    • Apple Podcasts
    • Spotify
    • iHeartRadio
    • Amazon Music
    • Pandora
    • YouTube

    Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

    If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

    Thanks so much for listening!

    Afficher plus Afficher moins
    29 min
  • Global Medical Data Infrastructure for AI Systems with MedSyntra - Life Sciences Today Podcast Episode 52
    Mar 13 2026

    We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Asta Ratkeviciene, Co‑Founder and CEO at MedSyntra. In this episode of Life Sciences Today, I talk with Ratkeviciene about building a global, ethically sourced medical imaging data infrastructure across radiology, pathology, oncology, and women’s healthcare. Ratkeviciene explains how MedSyntra aggregates and de-identifies millions of imaging studies, provides a highly curated data marketplace and platform for institutions that require data sovereignty, and partners with clinical experts for annotation and external teams for model development. They discuss why imaging is the core focus, how population differences can degrade AI performance across geographies, MedSyntra’s evolving business model, and the biggest anti‑patterns Ratkeviciene sees in the medical AI ecosystem today.

    Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

    • What’s the most important thing people misunderstand about medical imaging data?
    • Who must have this infrastructure before they can deploy serious AI?
    • When did you realize you weren’t building a dataset—but infrastructure?
    • What early decision optimized for long-term trust rather than speed?
    • Where does ethical data sourcing actually slow you down commercially?
    • Have you walked away from data that would have helped the business—but violated your principles?
    • Do you think ethical language is sometimes used to hide poor data practices?
    • Why do imaging AI models quietly fail when they cross borders?
    • When does population bias show up—training or deployment?
    • Why can’t this be solved with more data alone?
    • How do you reconcile local data control with global AI learning?
    • Do we end up with federated intelligence—or fragmented ecosystems?
    • What’s harder: collecting imaging data or producing clinically meaningful labels?
    • If annotation quality doubled, what would that unlock that most people aren’t expecting?
    • What’s the biggest anti-pattern you see in medical AI today?
    • Ten years from now, what will seem obvious about medical imaging AI that people are still ignoring today?

    Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

    Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

    • Apple Podcasts
    • Spotify
    • iHeartRadio
    • Amazon Music
    • Pandora
    • YouTube

    Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

    If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

    Thanks so much for listening!

    Afficher plus Afficher moins
    Indisponible
  • How PathKeeper Surgical is Changing Spine Surgery - Life Sciences Today Podcast Episode 51
    Mar 6 2026

    We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Erez Lampert, Founder and CEO at PathKeeper Surgical! I talk with Lampert about his journey from Israel’s aerospace industry and Invisalign’s Itero scanner to founding PathKeeper in 2018–2019. We dig into the core problem in spine surgery—surgeons “flying blind” between low‑cost, high‑radiation fluoroscopy and ultra‑expensive robotics—and how PathKeeper offers a third way using optical 3D imaging and AI. Erez explains their dual business model (capital + disposables, plus a “razor blade” model via implant partners in a $10B US spine market), and how strategic deals with High Ridge Medical (Zimmer Biomet spine) and Vizient unlock scalable US commercialization without a 50‑person direct sales team. The conversation challenges the myth that Israelis don’t know how to sell in the US, reframing success as understanding gatekeepers, GPOs, and distribution science rather than just raising $50M and hiring a big sales force.

    Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

    • What problem are spine surgeons facing today, and why is “flying blind” so dangerous?
    • How does PathKeeper’s 3D imaging + AI platform actually work in the OR, and how is it different from fluoroscopy and million‑dollar robots?
    • What is PathKeeper’s business model, and how does the implant “razor blade” model create leverage in a $10B US spine market?
    • How did the High Ridge Medical and Vizient deals come together, and what do they change for commercialization?
    • Why is the common investor advice, “raise $50M and build a huge US sales team’ the wrong playbook here?
    • What are the biggest anti‑patterns in the spine/med‑device industry today?

    Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

    Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

    • Apple Podcasts
    • Spotify
    • iHeartRadio
    • Amazon Music
    • Pandora
    • YouTube

    Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

    If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

    Thanks so much for listening!

    Afficher plus Afficher moins
    30 min